• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
OSL

ONCOSIL MEDICAL LTD - Announcements

1.80% ! $1.09
Market Cap $20.51M  !

OncoSil Medical Ltd is an Australia-based medical device company focused on localized... OncoSil Medical Ltd is an Australia-based medical device company focused on localized treatments for patients with unresectable locally advanced pancreatic cancer (LAPC). The Company is focused on the development and commercialization of its lead product candidate, the OncoSil localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. The Company has developed a cancer treatment device, the OncoSil brachytherapy device, which is a critical component of a brachytherapy treatment for locally advanced unresectable pancreatic cancer. The OncoSil device delivers a targeted intratumoral placement of Phosphorous-32 (32P) in the treatment of locally advanced unresectable pancreatic cancer. The OncoSil device has received a device designation in the European Union, United Kingdom and United States for the treatment of locally advanced unresectable pancreatic cancer in combination with chemotherapy.More

Announcements



OSL Becoming a substantial holder12/05/20 download Created with Sketch. 83.1KB
OSL OncoSil Entitlement Offer BookletPRICE SENSITIVE12/05/20 download Created with Sketch. 503.35KB
OSL Ceasing to be a substantial holder08/05/20 download Created with Sketch. 347.93KB
OSL Appendix 2A08/05/20 download Created with Sketch. 173.17KB
OSL Cleansing Notice08/05/20 download Created with Sketch. 75.35KB
OSL Allotment of Securities under Institutional PlacementPRICE SENSITIVE08/05/20 download Created with Sketch. 95.15KB
OSL Proposed issue of Securities - OSLPRICE SENSITIVE04/05/20 download Created with Sketch. 36.7KB
OSL Letter to ineligible shareholders04/05/20 download Created with Sketch. 136.28KB
OSL Cleansing notice04/05/20 download Created with Sketch. 388.32KB
OSL Investor PresentationPRICE SENSITIVE04/05/20 download Created with Sketch. 2.82MB
OSL OncoSil launches Capital RaisingPRICE SENSITIVE04/05/20 download Created with Sketch. 472.3KB
OSL OncoSil to present at Virtual Health Conference04/05/20 download Created with Sketch. 205.53KB
OSL OncoSil submits for ASEAN and APAC approvalsPRICE SENSITIVE04/05/20 download Created with Sketch. 218.35KB
OSL OncoSil appoints Nigel Lange as EMEA President04/05/20 download Created with Sketch. 457.76KB
OSL Appendix 4C - quarterlyPRICE SENSITIVE30/04/20 download Created with Sketch. 508.53KB
OSL Trading HaltPRICE SENSITIVE29/04/20 download Created with Sketch. 205.63KB
OSL Shares forfeited and cancelled16/04/20 download Created with Sketch. 198.9KB
OSL Ceasing to be a substantial holder07/04/20 download Created with Sketch. 179.99KB
OSL Oncosil breakthrough device receives CE Marking approvalPRICE SENSITIVE01/04/20 download Created with Sketch. 231.96KB
OSL Appointment of CFO and Company Secretary31/03/20 download Created with Sketch. 138.83KB
OSL Clarification StatementPRICE SENSITIVE27/03/20 download Created with Sketch. 140.73KB
OSL Pause in TradingPRICE SENSITIVE27/03/20 download Created with Sketch. 115.1KB
OSL Appendix 2A27/03/20 download Created with Sketch. 477.48KB
OSL Appendix 2A25/03/20 download Created with Sketch. 484.09KB
OSL Becoming and changing substantial holding18/03/20 download Created with Sketch. 492.64KB
OSL FDA Grants Breakthrough Device DesignationPRICE SENSITIVE18/03/20 download Created with Sketch. 192.2KB
OSL Change of Director's Interest Notice11/03/20 download Created with Sketch. 584.53KB
OSL Half Yearly Report and AccountsPRICE SENSITIVE27/02/20 download Created with Sketch. 459.19KB
OSL Ceasing to be a substantial holder21/02/20 download Created with Sketch. 85.75KB
OSL Change in substantial holding18/02/20 download Created with Sketch. 132.56KB
OSL Appendix 4C - quarterlyPRICE SENSITIVE30/01/20 download Created with Sketch. 337.4KB
OSL Change in substantial holding24/01/20 download Created with Sketch. 413.51KB
OSL CE Mark UpdatePRICE SENSITIVE19/11/19 download Created with Sketch. 251.89KB
OSL Becoming a substantial holder15/11/19 download Created with Sketch. 342.73KB
OSL Positive CE Mark Status ReportPRICE SENSITIVE01/11/19 download Created with Sketch. 139.51KB
OSL Appendix 4C - quarterlyPRICE SENSITIVE31/10/19 download Created with Sketch. 560.34KB
OSL Results of Meeting29/10/19 download Created with Sketch. 205.49KB
OSL OncoSil AGM CEO PresentationPRICE SENSITIVE29/10/19 download Created with Sketch. 2.85MB
OSL Updated Clinical Evaluation Report to BSIPRICE SENSITIVE28/10/19 download Created with Sketch. 445.65KB
OSL Receipt of $3.8M R&D Tax IncentivePRICE SENSITIVE18/10/19 download Created with Sketch. 140.03KB
OSL Positive Regulatory Updates11/10/19 download Created with Sketch. 182.49KB
OSL Changes in Senior Management30/09/19 download Created with Sketch. 252.98KB
OSL 2019 Annual Report27/09/19 download Created with Sketch. 5.02MB
OSL 2019 Notice of General Meeting & Proxy Form27/09/19 download Created with Sketch. 1.32MB
OSL 2019 Appendix 4G and Corporate Governance Statement27/09/19 download Created with Sketch. 608.48KB
OSL Change of Director's Interest Notice - Amended11/09/19 download Created with Sketch. 255.72KB
OSL Change of Director's Interest Notice - Amended11/09/19 download Created with Sketch. 257.31KB
OSL Change of Director's Interest Notice09/09/19 download Created with Sketch. 255.68KB
OSL Change of Director's Interest Notice28/08/19 download Created with Sketch. 257.12KB
OSL Appendix 4E and Full Year Statutory AccountsPRICE SENSITIVE23/08/19 download Created with Sketch. 1.16MB
OSL Appendix 4C - quarterlyPRICE SENSITIVE31/07/19 download Created with Sketch. 909.43KB
OSL CE Marking Update30/07/19 download Created with Sketch. 442.6KB
OSL Response to ASX Price QueryPRICE SENSITIVE26/07/19 download Created with Sketch. 697.9KB
OSL Ceasing to be a substantial holder02/07/19 download Created with Sketch. 431.6KB
OSL Becoming a substantial holder02/07/19 download Created with Sketch. 481.66KB
OSL Change in substantial holding28/06/19 download Created with Sketch. 94.68KB
OSL Positive Overall Survival data released at ASCO 2019 Chicago04/06/19 download Created with Sketch. 871.98KB
OSL Change of Director's Interest Notice09/05/19 download Created with Sketch. 256.73KB
OSL Change of Director's Interest Notice03/05/19 download Created with Sketch. 256.3KB
OSL Appendix 4C - quarterlyPRICE SENSITIVE30/04/19 download Created with Sketch. 904.58KB
OSL Loan Share Vesting Conditions Met18/04/19 download Created with Sketch. 631.66KB
OSL Change of Director's Interest Notice02/04/19 download Created with Sketch. 256.08KB
OSL Update - CE Marking ApplicationPRICE SENSITIVE29/03/19 download Created with Sketch. 543.45KB
OSL CE Marking UpdatePRICE SENSITIVE25/03/19 download Created with Sketch. 545.61KB
OSL Half Yearly Report and AccountsPRICE SENSITIVE20/02/19 download Created with Sketch. 981.79KB
OSL Appendix 4C - quarterlyPRICE SENSITIVE31/01/19 download Created with Sketch. 1.06MB
OSL Initial Director's Interest Notice11/12/18 download Created with Sketch. 221.67KB
OSL Director Appointment/Resignation10/12/18 download Created with Sketch. 656.45KB
OSL Loan Share Vesting Conditions Met02/11/18 download Created with Sketch. 631.02KB
OSL Appendix 3B31/10/18 download Created with Sketch. 718.17KB
OSL Results of Annual General Meeting 2018 - Amended30/10/18 download Created with Sketch. 633.06KB
OSL Results of Annual General Meeting 201830/10/18 download Created with Sketch. 633.24KB
OSL 2018 AGM CEO Presentation30/10/18 download Created with Sketch. 2.18MB
OSL Appendix 4C - quarterlyPRICE SENSITIVE29/10/18 download Created with Sketch. 1.12MB
OSL PanCo Study Interim AnalysisPRICE SENSITIVE25/10/18 download Created with Sketch. 834.73KB
OSL 2018 Notice of General Meeting & Proxy Form28/09/18 download Created with Sketch. 425.83KB
OSL 2018 Annual Report28/09/18 download Created with Sketch. 1.63MB
OSL 2018 Appendix 4G and Corporate Governance Statement28/09/18 download Created with Sketch. 603.32KB
OSL R&D Refund - 2018 Financial YearPRICE SENSITIVE24/09/18 download Created with Sketch. 638.37KB
OSL IQVIA appointed EU Market Access and Reimbursement AdvisorPRICE SENSITIVE30/08/18 download Created with Sketch. 728.53KB
OSL Preliminary Final ReportPRICE SENSITIVE22/08/18 download Created with Sketch. 1.89MB
OSL Oncosil Company Update Presentation26/07/18 download Created with Sketch. 2.13MB
OSL Appendix 4C & Quarterly UpdatePRICE SENSITIVE25/07/18 download Created with Sketch. 1.07MB
OSL OSL to present at Monsoon Communications Investor Event05/07/18 download Created with Sketch. 2.57MB
OSL OncoSil Company Update Presentation04/06/18 download Created with Sketch. 2.03MB
OSL Response to Price QueryPRICE SENSITIVE31/05/18 download Created with Sketch. 1002.99KB
OSL Appendix 3Y - Dr Roger Aston18/05/18 download Created with Sketch. 257.64KB
OSL Appendix 3Y - Dr Chris Roberts18/05/18 download Created with Sketch. 257.85KB
OSL Appendix 3Y - Dr Martin Cross18/05/18 download Created with Sketch. 257.05KB
OSL Appendix 3B17/05/18 download Created with Sketch. 726.49KB
OSL Results of Extraordinary General Meeting 201814/05/18 download Created with Sketch. 553.84KB
OSL Oncosil submits Clinical Study Report to Notified BodyPRICE SENSITIVE14/05/18 download Created with Sketch. 660.34KB
OSL OSL to present at Finance News Network Investor Session02/05/18 download Created with Sketch. 2.46MB
OSL Appendix 3Y - Dr Martin Cross Share Purchase Plan26/04/18 download Created with Sketch. 255.36KB
OSL Appendix 3Y - Daniel Kenny Share Purchase Plan26/04/18 download Created with Sketch. 256.62KB
OSL Appendix 3Y - Dr Chris Roberts Share Purchase Plan26/04/18 download Created with Sketch. 256.02KB
OSL Appendix 4C & Quarterly UpdatePRICE SENSITIVE26/04/18 download Created with Sketch. 1007.79KB
OSL Appendix 3B - Share Purchase Plan20/04/18 download Created with Sketch. 724.11KB
OSL ASIC Form 48420/04/18 download Created with Sketch. 518.04KB
OSL OncoSil Medical raises $4.0m from Share Purchase Plan19/04/18 download Created with Sketch. 495.84KB
OSL Becoming a substantial holder
12/05/20 download Created with Sketch. 83.1KB
OSL OncoSil Entitlement Offer Booklet
12/05/20PRICE SENSITIVE download Created with Sketch. 503.35KB
OSL Ceasing to be a substantial holder
08/05/20 download Created with Sketch. 347.93KB
OSL Appendix 2A
08/05/20 download Created with Sketch. 173.17KB
OSL Cleansing Notice
08/05/20 download Created with Sketch. 75.35KB
OSL Allotment of Securities under Institutional Placement
08/05/20PRICE SENSITIVE download Created with Sketch. 95.15KB
OSL Proposed issue of Securities - OSL
04/05/20PRICE SENSITIVE download Created with Sketch. 36.7KB
OSL Letter to ineligible shareholders
04/05/20 download Created with Sketch. 136.28KB
OSL Cleansing notice
04/05/20 download Created with Sketch. 388.32KB
OSL Investor Presentation
04/05/20PRICE SENSITIVE download Created with Sketch. 2.82MB
OSL OncoSil launches Capital Raising
04/05/20PRICE SENSITIVE download Created with Sketch. 472.3KB
OSL OncoSil to present at Virtual Health Conference
04/05/20 download Created with Sketch. 205.53KB
OSL OncoSil submits for ASEAN and APAC approvals
04/05/20PRICE SENSITIVE download Created with Sketch. 218.35KB
OSL OncoSil appoints Nigel Lange as EMEA President
04/05/20 download Created with Sketch. 457.76KB
OSL Appendix 4C - quarterly
30/04/20PRICE SENSITIVE download Created with Sketch. 508.53KB
OSL Trading Halt
29/04/20PRICE SENSITIVE download Created with Sketch. 205.63KB
OSL Shares forfeited and cancelled
16/04/20 download Created with Sketch. 198.9KB
OSL Ceasing to be a substantial holder
07/04/20 download Created with Sketch. 179.99KB
OSL Oncosil breakthrough device receives CE Marking approval
01/04/20PRICE SENSITIVE download Created with Sketch. 231.96KB
OSL Appointment of CFO and Company Secretary
31/03/20 download Created with Sketch. 138.83KB
OSL Clarification Statement
27/03/20PRICE SENSITIVE download Created with Sketch. 140.73KB
OSL Pause in Trading
27/03/20PRICE SENSITIVE download Created with Sketch. 115.1KB
OSL Appendix 2A
27/03/20 download Created with Sketch. 477.48KB
OSL Appendix 2A
25/03/20 download Created with Sketch. 484.09KB
OSL Becoming and changing substantial holding
18/03/20 download Created with Sketch. 492.64KB
OSL FDA Grants Breakthrough Device Designation
18/03/20PRICE SENSITIVE download Created with Sketch. 192.2KB
OSL Change of Director's Interest Notice
11/03/20 download Created with Sketch. 584.53KB
OSL Half Yearly Report and Accounts
27/02/20PRICE SENSITIVE download Created with Sketch. 459.19KB
OSL Ceasing to be a substantial holder
21/02/20 download Created with Sketch. 85.75KB
OSL Change in substantial holding
18/02/20 download Created with Sketch. 132.56KB
OSL Appendix 4C - quarterly
30/01/20PRICE SENSITIVE download Created with Sketch. 337.4KB
OSL Change in substantial holding
24/01/20 download Created with Sketch. 413.51KB
OSL CE Mark Update
19/11/19PRICE SENSITIVE download Created with Sketch. 251.89KB
OSL Becoming a substantial holder
15/11/19 download Created with Sketch. 342.73KB
OSL Positive CE Mark Status Report
01/11/19PRICE SENSITIVE download Created with Sketch. 139.51KB
OSL Appendix 4C - quarterly
31/10/19PRICE SENSITIVE download Created with Sketch. 560.34KB
OSL Results of Meeting
29/10/19 download Created with Sketch. 205.49KB
OSL OncoSil AGM CEO Presentation
29/10/19PRICE SENSITIVE download Created with Sketch. 2.85MB
OSL Updated Clinical Evaluation Report to BSI
28/10/19PRICE SENSITIVE download Created with Sketch. 445.65KB
OSL Receipt of $3.8M R&D Tax Incentive
18/10/19PRICE SENSITIVE download Created with Sketch. 140.03KB
OSL Positive Regulatory Updates
11/10/19 download Created with Sketch. 182.49KB
OSL Changes in Senior Management
30/09/19 download Created with Sketch. 252.98KB
OSL 2019 Annual Report
27/09/19 download Created with Sketch. 5.02MB
OSL 2019 Notice of General Meeting & Proxy Form
27/09/19 download Created with Sketch. 1.32MB
OSL 2019 Appendix 4G and Corporate Governance Statement
27/09/19 download Created with Sketch. 608.48KB
OSL Change of Director's Interest Notice - Amended
11/09/19 download Created with Sketch. 255.72KB
OSL Change of Director's Interest Notice - Amended
11/09/19 download Created with Sketch. 257.31KB
OSL Change of Director's Interest Notice
09/09/19 download Created with Sketch. 255.68KB
OSL Change of Director's Interest Notice
28/08/19 download Created with Sketch. 257.12KB
OSL Appendix 4E and Full Year Statutory Accounts
23/08/19PRICE SENSITIVE download Created with Sketch. 1.16MB
OSL Appendix 4C - quarterly
31/07/19PRICE SENSITIVE download Created with Sketch. 909.43KB
OSL CE Marking Update
30/07/19 download Created with Sketch. 442.6KB
OSL Response to ASX Price Query
26/07/19PRICE SENSITIVE download Created with Sketch. 697.9KB
OSL Ceasing to be a substantial holder
02/07/19 download Created with Sketch. 431.6KB
OSL Becoming a substantial holder
02/07/19 download Created with Sketch. 481.66KB
OSL Change in substantial holding
28/06/19 download Created with Sketch. 94.68KB
OSL Positive Overall Survival data released at ASCO 2019 Chicago
04/06/19 download Created with Sketch. 871.98KB
OSL Change of Director's Interest Notice
09/05/19 download Created with Sketch. 256.73KB
OSL Change of Director's Interest Notice
03/05/19 download Created with Sketch. 256.3KB
OSL Appendix 4C - quarterly
30/04/19PRICE SENSITIVE download Created with Sketch. 904.58KB
OSL Loan Share Vesting Conditions Met
18/04/19 download Created with Sketch. 631.66KB
OSL Change of Director's Interest Notice
02/04/19 download Created with Sketch. 256.08KB
OSL Update - CE Marking Application
29/03/19PRICE SENSITIVE download Created with Sketch. 543.45KB
OSL CE Marking Update
25/03/19PRICE SENSITIVE download Created with Sketch. 545.61KB
OSL Half Yearly Report and Accounts
20/02/19PRICE SENSITIVE download Created with Sketch. 981.79KB
OSL Appendix 4C - quarterly
31/01/19PRICE SENSITIVE download Created with Sketch. 1.06MB
OSL Initial Director's Interest Notice
11/12/18 download Created with Sketch. 221.67KB
OSL Director Appointment/Resignation
10/12/18 download Created with Sketch. 656.45KB
OSL Loan Share Vesting Conditions Met
02/11/18 download Created with Sketch. 631.02KB
OSL Appendix 3B
31/10/18 download Created with Sketch. 718.17KB
OSL Results of Annual General Meeting 2018 - Amended
30/10/18 download Created with Sketch. 633.06KB
OSL Results of Annual General Meeting 2018
30/10/18 download Created with Sketch. 633.24KB
OSL 2018 AGM CEO Presentation
30/10/18 download Created with Sketch. 2.18MB
OSL Appendix 4C - quarterly
29/10/18PRICE SENSITIVE download Created with Sketch. 1.12MB
OSL PanCo Study Interim Analysis
25/10/18PRICE SENSITIVE download Created with Sketch. 834.73KB
OSL 2018 Notice of General Meeting & Proxy Form
28/09/18 download Created with Sketch. 425.83KB
OSL 2018 Annual Report
28/09/18 download Created with Sketch. 1.63MB
OSL 2018 Appendix 4G and Corporate Governance Statement
28/09/18 download Created with Sketch. 603.32KB
OSL R&D Refund - 2018 Financial Year
24/09/18PRICE SENSITIVE download Created with Sketch. 638.37KB
OSL IQVIA appointed EU Market Access and Reimbursement Advisor
30/08/18PRICE SENSITIVE download Created with Sketch. 728.53KB
OSL Preliminary Final Report
22/08/18PRICE SENSITIVE download Created with Sketch. 1.89MB
OSL Oncosil Company Update Presentation
26/07/18 download Created with Sketch. 2.13MB
OSL Appendix 4C & Quarterly Update
25/07/18PRICE SENSITIVE download Created with Sketch. 1.07MB
OSL OSL to present at Monsoon Communications Investor Event
05/07/18 download Created with Sketch. 2.57MB
OSL OncoSil Company Update Presentation
04/06/18 download Created with Sketch. 2.03MB
OSL Response to Price Query
31/05/18PRICE SENSITIVE download Created with Sketch. 1002.99KB
OSL Appendix 3Y - Dr Roger Aston
18/05/18 download Created with Sketch. 257.64KB
OSL Appendix 3Y - Dr Chris Roberts
18/05/18 download Created with Sketch. 257.85KB
OSL Appendix 3Y - Dr Martin Cross
18/05/18 download Created with Sketch. 257.05KB
OSL Appendix 3B
17/05/18 download Created with Sketch. 726.49KB
OSL Results of Extraordinary General Meeting 2018
14/05/18 download Created with Sketch. 553.84KB
OSL Oncosil submits Clinical Study Report to Notified Body
14/05/18PRICE SENSITIVE download Created with Sketch. 660.34KB
OSL OSL to present at Finance News Network Investor Session
02/05/18 download Created with Sketch. 2.46MB
OSL Appendix 3Y - Dr Martin Cross Share Purchase Plan
26/04/18 download Created with Sketch. 255.36KB
OSL Appendix 3Y - Daniel Kenny Share Purchase Plan
26/04/18 download Created with Sketch. 256.62KB
OSL Appendix 3Y - Dr Chris Roberts Share Purchase Plan
26/04/18 download Created with Sketch. 256.02KB
OSL Appendix 4C & Quarterly Update
26/04/18PRICE SENSITIVE download Created with Sketch. 1007.79KB
OSL Appendix 3B - Share Purchase Plan
20/04/18 download Created with Sketch. 724.11KB
OSL ASIC Form 484
20/04/18 download Created with Sketch. 518.04KB
OSL OncoSil Medical raises $4.0m from Share Purchase Plan
19/04/18 download Created with Sketch. 495.84KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$1.09
Change
-0.020(1.80%)
Mkt cap ! $20.51M
Open High Low Value Volume
$1.11 $1.12 $1.08 $19.98K 18.08K

Buyers (Bids)

No. Vol. Price($)
3 3196 $1.08
 

Sellers (Offers)

Price($) Vol. No.
$1.09 3598 1
View Market Depth
Last trade - 16.10pm 08/08/2025 (20 minute delay) ?
OSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.